Zhuhai Resplip Pharmaceutical Technology

Resplip Pharmaceutical is a clinical-stage biopharmaceutical company based in Zhuhai, China, specializing in the development of high-end inhaled medications for respiratory and systemic diseases. The company leverages its proprietary dry powder inhalation (DPI) and soft mist inhaler (SMI) technology platforms to create a robust pipeline of generic and innovative drugs. Its lead programs target major respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, aiming to provide more effective and accessible treatment options. Resplip's expertise spans drug formulation, device design, and large-scale manufacturing, positioning it as a leader in the complex inhaled drug market in China.